Global Veterinary Molecular Diagnostics Market Report 2026–2030: Data-Driven Growth Insights
Uncover key drivers, emerging technologies, and competitive movements shaping the inorganic ceramic membrane market from 2026–2035 with trusted insights from The Business Research Company
How much larger will the Veterinary Molecular Diagnostics Market be in 2030 compared with 2026?
The veterinary molecular diagnostics market size has experienced robust growth in recent years. It is forecast to increase from $0.7 billion in 2025 to $0.77 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.9%. This expansion in the past can be linked to the growing incidence of infectious and genetic animal diseases, ongoing technological advancements in molecular biology, the increase in companion and livestock animal populations, enhanced veterinary awareness and training initiatives, and the widespread adoption of conventional molecular diagnostic kits.
The veterinary molecular diagnostics market size is projected to experience robust expansion in the coming years. It is anticipated to grow to $1.11 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 9.6%. The expansion during this forecast period can be attributed to a rising need for rapid and accurate molecular diagnostics, the adoption of NGS and high-throughput platforms, the broadening of veterinary genomics services, the integration of AI-driven diagnostic analysis, and an increasing emphasis on preventive veterinary care through molecular testing. Significant trends expected during the forecast period include the greater use of PCR and RT-PCR-based diagnostics, the growing embrace of next-generation sequencing (NGS) in veterinary medicine, the development of multiplex diagnostic kits for infectious diseases, the incorporation of molecular diagnostics into routine veterinary care, and the availability of automation and high-throughput molecular testing solutions.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20687&type=smp
What Drivers Are Guiding Growth Patterns In The Veterinary Molecular Diagnostics Market?
A significant incidence of zoonotic diseases is anticipated to drive forward the expansion of the veterinary molecular diagnostics market. These are infectious illnesses communicable from animals to humans, with origins that can include bacteria, viruses, parasites, or fungi. Examples of prevalent zoonotic conditions encompass rabies, Lyme disease, salmonellosis, toxoplasmosis, among others. Factors affecting the spread of zoonotic diseases involve deforestation, wildlife exploitation, intensive animal farming practices, biodiversity reduction, and human population movement. Early detection of zoonotic diseases in animals through veterinary molecular diagnostics aids in preventing human transmission. Furthermore, these diagnostics enhance disease management through prompt and precise pathogen identification. For example, data from December 2025, provided by the European Centre for Disease Prevention and Control (ECDC), a government agency based in Sweden, indicated that in 2024, reported human cases of significant zoonotic diseases, specifically campylobacteriosis (168,396 cases) and salmonellosis (79,703 cases), persistently rose, underscoring a considerable and continuing occurrence of zoonoses across Europe. Consequently, the widespread occurrence of zoonotic diseases is propelling the veterinary molecular diagnostics market.
How Is The Veterinary Molecular Diagnostics Market Divided Into Segments?
The veterinary molecular diagnostics market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments
2) By Animal Type: Companion Animals, Livestock Animals
3) By Application: Infectious Diseases, Genetic Diseases, Other Applications
4) By End-User: Diagnostic Laboratories, Veterinary Clinics, Veterinary Hospitals, Other End-Users
Subsegments:
1) By Kits And Reagents: Polymerase Chain Reaction (PCR) Kits, Reverse Transcription PCR (RT-PCR) Kits, Real-Time PCR Kits, Nucleic Acid Extraction Kits, Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Hybridization Kits, Reagents For Next-Generation Sequencing (NGS)
2) By Instruments: PCR Machines (Thermal Cyclers), Real-Time PCR Machines, Nucleic Acid Analyzers, Gel Electrophoresis Equipment, DNA Sequencers, Automated Liquid Handling Systems, Molecular Imaging Systems
Which Trends Are Influencing The Development Of The Veterinary Molecular Diagnostics Market?
Leading firms within the veterinary molecular diagnostics market are prioritizing automation and scalability in their diagnostic technologies, including high-volume testing machines, with the goal of enhancing diagnostic accuracy, boosting testing efficiency, and accelerating disease detection in animals. These high-volume testing machines represent sophisticated diagnostic equipment, engineered to efficiently handle substantial numbers of samples, thereby facilitating swift and precise analysis in laboratory or clinical environments, proving especially valuable for extensive testing operations. An example of this is seen in June 2023, when Iowa State University’s Veterinary Diagnostic Laboratory (VDL), a US-based university, launched SmartChip, a state-of-the-art molecular diagnostic testing device featuring quantitative polymerase chain reaction (qPCR) testing technology. This novel instrument is capable of processing over 5,000 samples on a single plate, which is no larger than a postage stamp. Its testing capacity is significantly amplified when integrated with a 384-sample system that includes automated handling capabilities. SmartChip testing employs microfluidic technology to pinpoint specific targets within samples, using a volume 100 times smaller than the volume utilized by the VDL’s standard 96-well machines.
Which Key Players Are Driving Competition In The Veterinary Molecular Diagnostics Market?
Major companies operating in the veterinary molecular diagnostics market are Roche Diagnostics Corporation, Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Illumina Inc., PerkinElmer Inc., bioMérieux S.A., IDEXX Laboratories Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., LGC Group Ltd., Neogen Corporation, Abcam plc, Eiken Chemical Co. Ltd., Bioneer Corporation, INDICAL BIOSCIENCE GmbH, Biochek B.V., Ring Biotechnology Co. Ltd., Ingenetix GmbH, MiDOG Animal Diagnostics LLC, Biolab S.r.l., Bionote USA Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Is Projected To Lead The Veterinary Molecular Diagnostics Market During The Forecast Period?
North America was the largest region in the Veterinary Molecular Diagnostics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Veterinary Molecular Diagnostics Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20687&type=smp
Browse Through More Reports Similar to the Global Veterinary Molecular Diagnostics Market 2026, By The Business Research Company
Veterinary Vaccines Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-vaccines-global-market-report
Veterinary Parasiticides Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-parasiticides-global-market-report
Veterinary Antibiotics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
